Search Results 391-400 of 7923 for TNF

  1. A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    Objectives - Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic ...

  3. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    TG4010 is a suspension of recombinant Modified Vaccinia virus strain Ankara (MVA strain) carrying coding sequences for human MUC1 antigen and human interleukin- ...

  4. Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia - Mayo Clinic

    SCH 900776 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether cytarabine is more effective ...

  5. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...

  6. A Study Evaluating Fecal DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease - Mayo Clinic

    About this study. Cells with increased oncogene activity adopt a secretory phenotype. For example, increased levels of c-Src not only inhibit ...

  7. A Study to Evaluate the Safety and Effectiveness of Antithrombotics to Treat Hospitalized COVID-19 Patients - Mayo Clinic

    About this study. This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of ...

  8. A Study to Evaluate the Effectiveness and Safety of Elafibranor for Patients with Nonalcoholic Fatty Liver Disease - Mayo Clinic

    About this study. The first double-blind 72-week treatment period will assess the efficacy and safety of elafibranor on the resolution of NASH without ...

  9. The Incidence of Electrophysiologically Identified Froment-Rauber Nerve in the General Population - Mayo Clinic

    The purpose of this study is to determine the frequency of the presence of a normal variation of a nerve in the arm in the general population. Participation ...

  10. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 2 weeks prior to randomization. - Patients who have received acute, low ...